(Q52185494)

26 April 2018

title

Enhancement of latent inhibition in the rat at a high dose of clozapine. (English)

1 reference

26 April 2018

author name string

K M Trimble

series ordinal

1

1 reference

26 April 2018

R Bell

series ordinal

2

1 reference

26 April 2018

D J King

series ordinal

3

1 reference

26 April 2018

language of work or name

English

0 references

publication date

1 January 1998

1 reference

26 April 2018

Journal of Psychopharmacology

published in

1 reference

26 April 2018

volume

12

1 reference

26 April 2018

issue

2

1 reference

26 April 2018

page(s)

215-219

1 reference

26 April 2018

Clozapine: an atypical neuroleptic

cites work

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200213

The effects of ritanserin, RU 24969 and 8-OH-DPAT on latent inhibition in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200213

Haloperidol enhancement of latent inhibition: Relation to therapeutic action?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200213

Biochemical and behavioural properties of clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200213

Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200213

D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200213

The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200213

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200213

The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200213

Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200213

Extrapyramidal side effects of clozapine and haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200213

Clozapine: new research on efficacy and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200213

Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200213

Enhancement of latent inhibition in the rat by the atypical antipsychotic agent remoxipride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200213

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200213

Neural substrates of latent inhibition: the switching model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200213

Facilitation of latent inhibition by haloperidol in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200213

Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200213

Disruption of latent inhibition by acute administration of low doses of amphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200213

The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200213

10.1177/026988119801200213

21 January 2018

Identifiers

DOI

1 reference

26 April 2018

PubMed ID

9694034

1 reference

26 April 2018